If you have noticed high-strength retinol products disappearing from shelves or being reformulated, this is the result of new EU cosmetic regulations — commonly referred to as the "retinol ban" — that cap the concentration of retinol permitted in over-the-counter cosmetic products. This article explains what the regulation covers, why it was introduced, and what it means in practice.

This article is for educational purposes only. Tretinoin and other prescription retinoids are not affected by this regulation and remain available through licensed UK prescribers.

What the regulation actually says

EU Regulation 2024/996 is not a total ban on retinol — it is a concentration cap on over-the-counter cosmetic products:

• Face and hand products: maximum 0.3% retinol
• Body products: maximum 0.05% retinol

Products exceeding these limits must be reformulated or withdrawn from the market by May 2027. Many popular products previously contained 0.5%–1% retinol or higher — these will be affected.

The regulation applies to cosmetic products sold in the EU. The UK has its own regulatory framework post-Brexit, but UK regulators typically align closely with EU cosmetic safety decisions over time.

Why the regulation was introduced

The restriction was driven by the EU's Scientific Committee on Consumer Safety (SCCS) based on two primary concerns:

Cumulative vitamin A exposure

Vitamin A is fat-soluble and accumulates in the body. The SCCS identified a risk that consumers using high-strength retinol skincare products alongside dietary sources of vitamin A (dairy, fish, liver) and supplements could exceed the safe upper limit for total vitamin A intake. Excessive vitamin A accumulation can cause liver damage, weakened bones, and — most critically — birth defects if exposure occurs during pregnancy.

Skin barrier damage

Dermatologists have observed a significant increase in retinol-induced barrier disruption — chronic redness, peeling, and sensitivity — caused by consumers using high-strength products without clinical guidance. The cap is intended to reduce the risk of harm from unsupervised use.

What is not affected

The regulation applies only to cosmetic products. It does not affect prescription-strength retinoids including tretinoin, which are classified as medicines rather than cosmetics and are already subject to separate regulatory oversight. Prescription retinoids remain available through licensed UK prescribers following a medical assessment.

Retinaldehyde (retinal) and retinyl esters are subject to separate provisions and may be less affected depending on formulation.

What this means in practice

If you are currently using an OTC retinol product at 0.5% or above, it may be reformulated or discontinued before May 2027. The practical options are:

• Continue with a reformulated lower-concentration product — 0.3% retinol is still within the therapeutically active range for many users
• Consider retinaldehyde (retinal), which is one conversion step from retinoic acid and more potent than retinol at equivalent concentrations — currently less affected by the cap
• Discuss whether a prescription retinoid such as tretinoin is appropriate — prescription retinoids are significantly more potent than any OTC retinol and are not subject to this cap

For a full comparison of retinoid options from OTC to prescription, see our complete guide to retinol. For information on accessing prescription tretinoin in the UK, see our Tretinoin UK Buying Guide.

Frequently asked questions

Is retinol being banned in the UK?

Not banned — concentration-capped in cosmetic products. EU Regulation 2024/996 limits OTC retinol to 0.3% in face and hand products and 0.05% in body products, with a compliance deadline of May 2027. The UK has its own regulatory framework but typically aligns with EU cosmetic safety decisions.

Does this affect tretinoin?

No. Tretinoin is a prescription medicine, not a cosmetic product, and is not subject to this regulation. It remains available through licensed UK prescribers following a medical assessment.

Is 0.3% retinol still effective?

Yes — 0.3% retinol is within the therapeutically active range and will produce meaningful results with consistent use. The adjustment is most significant for users who were relying on 0.5%–1% products for more intensive treatment. For those finding 0.3% insufficient, retinaldehyde or prescription tretinoin are the logical next steps.

What is retinaldehyde and is it affected?

Retinaldehyde (retinal) is one conversion step from retinoic acid, making it more potent than retinol at equivalent concentrations. It is subject to separate provisions under the regulation and is currently less affected. It is available OTC and represents a useful bridge between retinol and prescription retinoids.

Should I stockpile high-strength retinol before May 2027?

There is no clinical reason to do so. If your current product is being discontinued, the alternatives — reformulated 0.3% products, retinaldehyde, or prescription tretinoin — are all viable options. Discuss with a clinician if you are unsure which is most appropriate for your skin.